Birchview Capital, LP - Mar 23, 2023 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (AZYO)

Role
10%+ Owner
Signature
Birchview Capital, LP By: /s/ Matthew Strobeck Matthew Strobeck, Managing Member of Birchview Capital GP, LLC, General Partner of Birchview Capital, LP
Stock symbol
AZYO
Transactions as of
Mar 23, 2023
Transactions value $
$206,958
Form type
4
Date filed
3/27/2023, 04:17 PM
Previous filing
Feb 13, 2023
Next filing
Feb 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AZYO Class A Common Stock Purchase $149K +100K +6.6% $1.49 1.62M Mar 23, 2023 See footnote F1, F2
transaction AZYO Class A Common Stock Purchase $14.9K +10K +0.62% $1.49 1.63M Mar 23, 2023 See footnote F1, F3
transaction AZYO Class A Common Stock Purchase $24.4K +18K +1.11% $1.35 1.64M Mar 24, 2023 See footnote F1, F2
transaction AZYO Class A Common Stock Purchase $2.71K +2K +0.12% $1.35 1.65M Mar 24, 2023 See footnote F1, F3
transaction AZYO Class A Common Stock Purchase $15.9K +10K +0.61% $1.59 1.66M Mar 27, 2023 See footnote F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.
F2 The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund.
F3 As specified in Table I, Birchview Capital, LP advises the acquired shares in a separately managed account ("SMA").
F4 As specified in Table I, Birchview Capital, LP advises the acquired shares in a different SMA other than the one noted above.